IGSF8 is an innate immune checkpoint and cancer immunotherapy target.
Li Y, Wu X, Sheng C, Liu H, Liu H, Tang Y, Liu C, Ding Q, Xie B, Xiao X, Zheng R, Yu Q, Guo Z, Ma J, Wang J, Gao J, Tian M, Wang W, Zhou J, Jiang L, Gu M, Shi S, Paull M, Yang G, Yang W, Landau S, Bao X, Hu X, Liu XS, Xiao T.
Li Y, et al. Among authors: liu xs.
Cell. 2024 Apr 18:S0092-8674(24)00355-6. doi: 10.1016/j.cell.2024.03.039. Online ahead of print.
Cell. 2024.
PMID: 38657602